Hypertensive disorders during pregnancy encompass various conditions, including preeclampsia, gestational hypertension, chronic hypertension, and preeclampsia superimposed on chronic hypertension. Accurate diagnosis is crucial for management decisions, timing of delivery, and assessing maternal prognosis. Healthcare providers must consider other medical disorders with similar features. PlGF-based tests can aid in ruling in or ruling out preeclampsia between 20+0 and 36+6 weeks of gestation, offering improved prediction capabilities. Differentiating between these disorders can be challenging, but careful examination of blood pressure trends, proteinuria, and end-organ dysfunction signs can help. Recurrence rates of preeclampsia in subsequent pregnancies are signicant, and it is associated with long-term maternal cardiovascular risks and diseases. Personalized management strategies and biomarkers hold promise for future research in preeclampsia, providing better prediction and intervention strategies for improved maternal and offspring outcomes.
